This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Published 16 December 2021 Last updated 20 January 2023 +show all updates
The following medicine has been added to the list: (Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens) Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices, and the following 6 medicines have been removed from the list: (HyQvia 10g/100ml solution for infusion and 5ml vials) Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials, (HyQvia 2.5g/25ml solution for infusion and 1.25ml vials) Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials, (HyQvia 30g/300ml solution for infusion and 15ml vials) Normal immunoglobulin human 30g/300ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 15ml vials, (HyQvia 5g/50ml solution for infusion and 2.5ml vials) Normal immunoglobulin human 5g/50ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 2.5ml vials, (Fotivda 1340microgram capsules) Tivozanib 1340microgram capsules, and (Fotivda 890microgram capsules) Tivozanib 890microgram capsules.
Changed '(Esperoct 5000 unit powder and solvent for solution for injection vials) Turoctocog alfa pegol 500 unit powder and solvent for solution for injection vials' to: '(Esperoct 500 unit powder and solvent for solution for injection vials) Turoctocog alfa pegol 500 unit powder and solvent for solution for injection vials'. Added the following medicines to the list: Ibandronic acid 50mg tablets; Lixisenatide 20mg / 0.2ml solution for injection 3ml pre-filled disposable devices; Potassium citrate 282mg / Potassium bicarbonate 527mg modified-release granules sachets sugar free; and Potassium citrate 847mg / Potassium bicarbonate 1.582g modified-release granules sachets sugar free.
28 products have been added to the list: Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials;Normal immunoglobulin human 5g/50ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 2.5ml vials;Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials;Normal immunoglobulin human 30g/300ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 15ml vials;Naloxone 1.8mg/0.1ml nasal spray unit dose;Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free;Interferon beta-1b 300microgram powder and solvent for solution for injection vials;Saxagliptin 2.5mg / Metformin 1g tablets;Saxagliptin 5mg / Dapagliflozin 10mg tablets;Eptacog alfa (activated) 1mg (50,000unit) powder and solvent for solution for injection pre-filled syringes;Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection pre-filled syringes;Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection pre-filled syringes;Eptacog alfa (activated) 8mg (400,000unit) powder and solvent for solution for injection pre-filled syringes;Turoctocog alfa pegol 1,000unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 1,500unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 2,000unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials;Turoctocog alfa pegol 500unit powder and solvent for solution for injection vials;Turoctocog alfa 250unit powder and solvent for solution for injection vials;Turoctocog alfa 500unit powder and solvent for solution for injection vials;Turoctocog alfa 1,000unit powder and solvent for solution for injection vials;Turoctocog alfa 1,500unit powder and solvent for solution for injection vials;Turoctocog alfa 2,000unit powder and solvent for solution for injection vials;Turoctocog alfa 3,000unit powder and solvent for solution for injection vials;Catridecacog 2,500unit powder and solvent for solution for injection vials;Nonacog beta pegol 1,000unit powder and solvent for solution for injection vials;Nonacog beta pegol 2,000unit powder and solvent for solution for injection vials;Nonacog beta pegol 500unit powder and solvent for solution for injection vials
Added 2 products to the list: Omalizumab 75mg/0.5ml solution for injection pre-filled syringes and Oxybutynin 3.9mg/24 hours transdermal patches.
Added: (NovoRapid FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Erenumab 140mg/1ml solution for injection pre-filled disposable devices; Erenumab 70mg/1ml solution for injection pre-filled disposable devices; Sarilumab 150mg/1.14ml solution for injection pre-filled syringes; Sarilumab 200mg/1.14ml solution for injection pre-filled syringes; Sarilumab 150mg/1.14ml solution for injection pre-filled disposable devices; Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices; Mitomycin 40mg powder and solvent for intravesical solution vials; Imatinib 100mg tablets; Imatinib 400mg tablets.Removed: Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free.Changed: Simulect 10mg powder and solvent forsolution for in
